4/4
08:00 am
opk
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
Medium
Report
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
4/3
08:48 am
opk
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication [Yahoo! Finance]
Low
Report
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication [Yahoo! Finance]
3/31
10:03 am
opk
Fortune [Fortune]
Neutral
Report
Fortune [Fortune]
3/19
08:04 am
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Medium
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
3/17
08:00 am
opk
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
Medium
Report
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
3/14
10:50 am
opk
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis [Yahoo! Finance]
Low
Report
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis [Yahoo! Finance]
3/13
08:43 am
opk
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting [Yahoo! Finance]
Low
Report
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting [Yahoo! Finance]
3/12
12:11 pm
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
3/12
08:36 am
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
3/4
08:52 am
opk
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication [Yahoo! Finance]
Medium
Report
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication [Yahoo! Finance]
3/3
11:02 pm
opk
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
OPKO Health, Inc. (NASDAQ: OPK) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/3
08:10 am
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
3/1
07:07 pm
opk
OPKO Health Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
OPKO Health Full Year 2024 Earnings: Beats Expectations [Yahoo! Finance]
3/1
02:36 am
opk
Opko Health (OPK) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Opko Health (OPK) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
2/28
10:40 am
opk
OPKO Health, Inc. (NASDAQ: OPK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $2.25 price target on the stock.
2/27
05:49 pm
opk
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results [Yahoo! Finance]
Low
Report
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results [Yahoo! Finance]
2/27
04:10 pm
opk
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
Low
Report
OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
2/24
06:04 am
opk
Katherine Stueland [CNBC]
Low
Report
Katherine Stueland [CNBC]
2/18
03:41 pm
opk
GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge [CNBC]
Low
Report
GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge [CNBC]
2/18
06:07 am
opk
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025 [Yahoo! Finance]
Low
Report
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025 [Yahoo! Finance]
2/14
08:37 am
opk
GeneDx launches ultrarapid whole genome sequencing for critically ill infants [Yahoo! Finance]
Low
Report
GeneDx launches ultrarapid whole genome sequencing for critically ill infants [Yahoo! Finance]
2/13
04:05 pm
opk
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
Low
Report
OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
2/13
08:54 am
opk
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients [Yahoo! Finance]
Low
Report
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients [Yahoo! Finance]
2/10
10:10 am
opk
GeneDx CEO wants genetic testing for every newborn [Yahoo! Finance Canada]
Low
Report
GeneDx CEO wants genetic testing for every newborn [Yahoo! Finance Canada]
1/15
02:10 am
opk
OPKO Health, Inc. (NASDAQ: OPK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
OPKO Health, Inc. (NASDAQ: OPK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.